These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4780896)

  • 1. [Administration of a new antimycobacterial combined therapy in leprosy in East Africa].
    Verhagen AR
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:36-9. PubMed ID: 4780896
    [No Abstract]   [Full Text] [Related]  

  • 2. A pilot study of leprosy treatment with a combination of various antileprosy drugs. Preliminary report.
    Blenska W; Kolakowska E
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:26-31. PubMed ID: 4780895
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the bacteriological effect of combined treatment with rifadin, sulfamethoxypyrazine, and isoniazide in lepromatous leprosy.
    Leiber DL; Verhagen AR
    Z Tropenmed Parasitol; 1973 Dec; 24():32-5. PubMed ID: 4592434
    [No Abstract]   [Full Text] [Related]  

  • 4. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
    Freerksen E; Rosenfeld M
    Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
    [No Abstract]   [Full Text] [Related]  

  • 5. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR; Gatt P
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research in the campaign against leprosy (author's transl)].
    Freerksen E
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1115-8. PubMed ID: 408667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Initial clinical results using new, experimentally developed therapeutic forms in leprosy].
    Rohde R
    Z Tropenmed Parasitol; 1973 Dec; 24():Suppl 1:40-52. PubMed ID: 4592436
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee 4: workshop on experimental chemotherapy of leprosy.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
    [No Abstract]   [Full Text] [Related]  

  • 12. Leprosy eradication project of Malta. First published report after 5 years running.
    Freerksen E; Rosenfeld M
    Chemotherapy; 1977; 23(5):356-86. PubMed ID: 332467
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current therapeutics in leprosy: resistance--therapeutic regimens--control strategy].
    Nebout M
    Acta Leprol; 1983; 1(3):151-8. PubMed ID: 6359803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug therapy for paucibacillary leprosy: experience in Bombay.
    Revankar CR; Ganapati R; Naik DD
    Indian J Lepr; 1985; 57(4):773-9. PubMed ID: 3835208
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of severe open cavitary pulmonary tuberculosis with a combination of rifampicin and isoprodian (author's transl)].
    Pereira V
    Prax Pneumol; 1976 Sep; 30(9):584-7. PubMed ID: 967829
    [No Abstract]   [Full Text] [Related]  

  • 20. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
    Warndorff van Diepen T; Mengistu G
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.